Clinical Trials Browser

Phase 2/3 × Interventional × Receptors, Bombesin × Clear all

NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Phase 2/3 Completed

122 enrolled 8 charts

Prostate Adenocarcinoma